This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cigna Study Supports Association Between Treated Periodontal Disease And Reduced Hospital Admissions And ER Visits, And Lower Medical Costs

Regular visits to the dentist may do more than just brighten your smile, they may also lead to fewer hospital visits and trips to the emergency room, as well as lower your medical costs. These are the conclusions from a three-year Cigna dental study that looked at the potential benefits of treated periodontal (gum) disease. The findings were recently presented at the International Association for Dental Research (IADR) conference in Seattle. IADR is a non-profit organization dedicated to advancing research and increasing knowledge to improve oral health worldwide.

“Advancing our understanding of how treatment for gum disease can affect overall health may help lead to the creation of evidence-based treatment standards that could benefit millions of people and simultaneously help reduce medical costs,” said Dr. Robert Genco, a member of Cigna's Dental Clinical Advisory Panel.

According to the Centers for Disease Control and Prevention (CDC), periodontal disease and tooth decay are the two biggest threats to dental health and are mostly seen in adults. Periodontal diseases are infections of the gums and bone that surround and support the teeth. Half of Americans aged 30 or older – 64.7 million people – have periodontitis, the more advanced form of periodontal disease.

Cigna’s study looked at periodontal patients from 2009 through 2011. On average, patients who received gum disease treatment had better outcomes than patients without treatment. Hospital admission rates were 149 per thousand (67%) lower, emergency room visits were 100 per thousand (54%) lower, and medical costs were $1,020 per year (28%) lower.

“These results suggest that treating gum disease has benefits beyond better oral health and may also help to control medical costs for some patients,” said Clay Hedlund D.D.S., Cigna's dental director. “We are pleased to be part of the dental community’s ongoing research into the links between good oral health and good overall health.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs